1. Somanchi BV, Stanton A, Webb M et al. Hand function after high dose rate brachytherapy for squamous cell carcinoma of the skin of the hand. Clin Oncol (R Coll Radiol) 2008; 20: 691-697.
2.
Ouhib Z, Kasper M, Perez-Calatayud J et al. Aspects of dosimetry and clinical practice of skin brachytherapy: the American Brachytherapy Society working group report. Brachytherapy 2015; 14: 840-858.
3.
Guinot JL, Rembielak A, Perez-Calatayud J et al. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol 2018; 126: 377-384.
4.
Rodríguez S, Arenas M, Gutiérrez C et al. Recommendations of the Spanish Brachytherapy Group (GEB) of SEOR and the Spanish Society of Medical Physics (SEFM) for HDR non-melanoma skin cancer brachytherapy. Clin Transl Oncol 2018; 20: 431-442.
5.
Cunha JAM, Flynn R, Bélanger C et al. Brachytherapy: future directions. Semin Radiat Oncol 2020; 30: 94-106.
6.
Pathak P, Thomas JJ, Baghwala A et al. Personalized brachytherapy: applications and future directions. Cancers (Basel) 2024; 16: 3424.
7.
Guix B, Finestres F, Tello JI et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000; 47: 95-102.
8.
Montero A, Hernanz R, Capuz AB et al. High-dose-rate plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer. Clin Transl Oncol 2009; 11: 760-764.
9.
Casey S, Awotwi-Pratt J, Bahl G. Surface mould brachytherapy for skin cancers: the British Columbia Cancer experience. Cureus 2019; 11: e6412.
10.
Brovchuk S, Park SJ, Shepil Z et al. High-dose-rate skin brachytherapy with interstitial, surface, or combined techniques. J Contemp Brachytherapy 2022; 14: 107-114.
11.
Gogineni E, Cai H, Carrillo D et al. Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face. J Contemp Brachytherapy 2021; 13: 51-58.
12.
Esmati E, Abyaneh R, Razzaghi S et al. Surface mold brachytherapy for head and neck non-melanoma skin cancer: local control rates and survival. J Contemp Brachytherapy 2024; 16: 323-334.
13.
Poltorak M, Banatkiewicz P, Poltorak L et al. Brachytherapy and 3D printing for skin cancer: a review paper. J Contemp Brachytherapy 2024; 16: 156-169.
14.
Bielęda G, Chicheł A, Boehlke M et al. 3D printing of individual skin brachytherapy applicator: design, manufacturing and early clinical results. J Contemp Brachytherapy 2022; 14: 205-214.
15.
Shah C, Ouhib Z, Kamrava M et al. The American Brachytherapy Society consensus statement for skin brachytherapy. Brachytherapy 2020; 19: 415-426.
16.
Laan RC, Nout RA, Dankelman J, van de Berg N. MRI-driven design of customised 3D-printed gynaecological brachytherapy applicators with curved needle channels. 3D Print Med 2019; 5: 8.
17.
Tang C, Yuan J, Guo H et al. Quantify the effect of air gap errors on skin dose for breast cancer radiotherapy. Front Oncol 2024; 14: 1390933.
18.
Delishaj D, Rembielak A, Manfredi B et al. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature. J Contemp Brachytherapy 2016; 8: 533-540.
19.
Laliscia C, Livi L, Saieva C et al. High-dose-rate brachytherapy for non-melanoma skin cancer: a single-institution experience. J Contemp Brachytherapy 2021; 13: 202-212.
20.
Tagliaferri L, Ciardo FG, Fionda B et al. Non-melanoma skin cancer treated by contact high-dose-rate radiotherapy (brachytherapy): a mono-institutional series and literature review. In Vivo 2021; 35: 2313-2319.
21.
Tormo A, Celada F, Rodriguez S et al. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy 2014; 6: 167-172.
22.
Wadhwa SS, Duggal N. A customized finger brachytherapy carrier. J Indian Prosthodont Soc 2014; 14: 326-329.
23.
Tagliaferri L, Lancellotta V, Fionda B et al. Subungual squamous cell carcinoma of the thumb treated by “function sparing approach” using contact radiotherapy (brachytherapy). Turk J Oncol 2019; 34: 298-301.
24.
Gupta A, Pandey R, Krishna A et al. Surface mould brachytherapy planning in giant cell tumour of the tendon sheath of finger and dosimetric comparison with external beam radiotherapy: a case report. J Radiother Pract 2022; 21: 289-293.
25.
Bellis R, Mills L, Lovatt C et al. Additive manufacturing (3D printing) in superficial brachytherapy: current applications and challenges. J Contemp Brachytherapy 2021; 13: 468-482.
26.
Zwierzchowski G, Bielęda G, Szymbor A et al. Personalized superficial HDR brachytherapy – dosimetric verification of dose distribution with lead shielding of critical organs in the head and neck region. J Pers Med 2022; 12: 1432.
27.
Rodríguez-Villalba S, Arenas M, Gutiérrez C et al. Recommendations of the Spanish brachytherapy group (GEB) of SEOR and the Spanish Society of Medical Physics (SEFM) for HDR non-melanoma skin cancer brachytherapy. Clin Transl Oncol 2018; 20: 431-442.
28.
Salamat F, Siavashpour Z, Sadeghi M et al. Dosimetric evaluation and Monte Carlo simulation of a new proposed surface brachytherapy mould. J Contemp Brachytherapy 2024; 16: 279-288.
29.
Jaberi R, Siavashpour Z, Zare Akha N et al. Validation of an individualized home-made superficial brachytherapy mold applied for deep nonmelanoma skin cancer. Rep Pract Oncol Radiother 2022; 27: 1010-1018.
30.
Olek D Jr, El-Ghamry MN, Deb N et al. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer – an analysis of 273 lesions. Brachytherapy 2018; 17: 601-608.
31.
Casey S, Bahl G, Awotwi-Pratt JB. High dose rate 192-Ir brachytherapy for basal cell carcinoma of the skin using a 3D printed surface mold: a case report. Cureus 2019; 11: e4913.
32.
Membrive Conejo I, Pera Cegarra O, Foro Arnalot P et al. High-dose-rate plesiotherapy with customized molds in non-melanoma skin cancer: efficacy and safety at 10 years – single institution experience. Clin Transl Oncol 2022; 24: 578-585.